Epidemiological surveillance data can be used to guide public health interventions, support funding, develop policy, and educate the community and specific populations in order to decrease burden. The purpose of this assignment it to analyze, interpret, and disseminate Morbidity and Mortality Weekly Report (MMWR) surveillance data to both technical and nontechnical audiences, and provide recommendations for public health action for a selected disease or heath issue using audience-appropriate language and information.

Select a MMWR health issue published within the past 5-10 years to disseminate data to a technical and nontechnical audience.  Select a technical audience, such as public health practitioners, clinicians and other health care providers, policymakers and other decision makers, and a nontechnical community group or target population. Provide the reason for the dissemination from the following, be specific, and provide details tailored to your data and health issue:

1. Educate about recent findings or accomplishments.
2. Elicit immediate action.
3. Solicit support or participation.
4. Justify program/prevention activities.
5. Prepare for an upcoming intervention or program.
6. Provide rationale to develop new policy or support current policy.

For the technical audience, create a PowerPoint presentation (10-13 slides)  to disseminate surveillance data from the MMWR report for a selected purpose using the slide headings outlined below. Include speaker notes for each slide. For your final slide, develop an educational “fact sheet” about the issue that is appropriate for a nontechnical community group or target population.

Add two additional slides for the Title and References slides.

Refer to Morbidity and Mortality Weekly Report (MMWR), “Introduction to Public Health Surveillance,” and “Data Dissemination” to assist you in completing this assignment.

PowerPoint Headings

1. Title Page: Include your health issue topic which identifies a specific technical and nontechnical audience and group member names.
2. Audience Appropriate Data Dissemination (1-2 slides): Explain the importance audience appropriate messages for data dissemination. Identify your health issue, technical and nontechnical audiences, and the reason for the dissemination
3. Data Collection (1-2 slides): Identify and describe a MMWR for a health issue and the data collection timeframe and methods.
4. Data Analysis (1-2 slides): Summarize the data and document the magnitude of the health issue using descriptive statistics (person, place, time), rates, include tables, graphs, maps, or charts.
5. Data Interpretation (1-2 slides): Summarize the report results and provide the implications for public health practice.
6. Recommendations for Action (1-2 slides): Provide recommendations or support for policy, policy development, funding for screening or implementation of an intervention or program to address the health issue. Include the factors (e.g., unique behaviors, exposures, or environmental factors) that contribute to the health issue that will be addressed.
7. Fact Sheet: Data Dissemination to a Nontechnical Audience (1 slide): On the last slide of your presentation, create an audience appropriate fact sheet that explains and brings awareness to the health issue and the steps in addressing/mitigating the health issue for a community group or population. Include both text and photos, images, or illustrations to make it eye catching and compelling.
8. Conclusion (1 slide)
9. References page

You are required to cite to a minimum of three sources to complete this assignment. Sources must be published within the last 5 years and appropriate for the assignment criteria and public health content.

 

Benchmark Information

This benchmark assignment assesses the following programmatic competencies:

MPH 2.1; MSN Public Health Nursing 6.2

Apply epidemiological methods to the breadth of settings and situations in public health practice.

  

Jack is a 54-year-old patient who has difficulty coming in for primary care visits. He sees cardiology, pulmonary clinic, and endocrine clinic for his comorbid conditions of diabetes mellitus, post-coronary artery bypass grafting (CABG) 2 years ago, and mild chronic obstructive pulmonary disease issues from a 30-year pack history of smoking. His last visit with you was over a year ago. Today, your registered nurse brings you a telephone triage call requesting a refill of his Crestor prescription, which was ordered by cardiology soon after his CABG. Per the electronic links to the cardiology service within your facility, the medication was due to be renewed about 2 months ago. His last lipid labs were a year ago and his last complete metabolic panel (CMP) was done at the same time. He was recently at the pulmonary clinic and his last recorded HgA1C was 9.0 from a visit to endocrine 4 months ago.

Review of records include a prescription for his hypertension (Lisinopril 20 mg daily), metformin 1,000 mg twice a day for his diabetes and no known medications for his pulmonary issues. The Crestor prescription appears to have multiple dosing levels over the past few refills.

His last vital signs were blood pressure 170/110 mm Hg, pulse 88, and respirations 22. His body mass index is 30 and he indicates a pain level of 4 out of 5. His pulse oximetry was 92% on room air.

1. How do you respond to this telephonic request?

2. What steps are required to get Jack’s therapeutic plan under control?

3. What is the role of the primary care provider in this scenario?  

A 58-year-old obese white male presents to ED with chief complaint of fever, chills, pain, and swelling in the right great toe. He states the symptoms came on very suddenly and he cannot put any weight on his foot. Physical exam reveals exquisite pain on any attempt to assess the right first metatarsophalangeal (MTP) joint. Past medical history positive for hypertension and Type II diabetes mellitus. Current medications include hydrochlorothiazide 50 mg po q am, and metformin 500 mg po bid. CBC normal except for elevated sedimentation rate (ESR) of 33 mm/hr and C-reactive protein (CRP) 24 mg/L. Metabolic panel normal. Uric acid level 6.7 mg/dl.

  

Therapy for Patients With Sleep/Wake Disorders

From negative changes in mood to problems concentrating, sleep/wake disorders can have a tremendous impact on patients’ lives. When patients suffer from these disorders, they often seek medical care with the intent of receiving medications to manage symptoms. However, many of the medications used to treat sleep/wake disorders may be addictive, making thorough patient assessments and close follow-up care essential. To prescribe appropriate therapies with patient safety in mind, you must understand not only the pathophysiology of these disorders but also the pharmacologic agents used to treat them.

This week, as you study therapies for individuals with sleep/wake disorders, you examine the assessment and treatment of patients with these disorders. You also explore ethical and legal implications of these therapies.

Learning Objectives

Students will:

· Synthesize concepts related to the psychopharmacologic treatment of patients

· Assess patient factors and history to develop personalized therapy plans for patients with sleep/wake disorders

· Analyze factors that influence pharmacokinetic and pharmacodynamic processes in patients requiring therapy for sleep/wake disorders

· Synthesize knowledge of providing care to patients presenting for sleep/wake disorders

· Analyze ethical and legal implications related to prescribing therapy for patients with sleep/wake disorders

  

Learning Resources

Required Readings (click to expand/reduce)

https://ezp.waldenulibrary.org/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=cat06423a&AN=wal.DSM5&site=eds-live&scope=site

https://ezp.waldenulibrary.org/login?qurl=https%3A%2F%2Fsearch.proquest.com%2Fdocview%2F2422903356%3Faccountid%3D14872

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388122/

https://j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com/wp-content/uploads/2017/07/PP_Narcolepsy.pdf

https://j2vjt3dnbra3ps7ll1clb4q2-wpengine.netdna-ssl.com/wp-content/uploads/2017/07/PP_NightWakingsChildren.pdf

https://jcsm.aasm.org/doi/pdf/10.5664/jcsm.6470

https://ezp.waldenulibrary.org/login?qurl=https%3A%2F%2Fsearch.proquest.com%2Fdocview%2F1720529955%3Faccountid%3D14872

Medication Resources (click to expand/reduce)

https://www.micromedexsolutions.com/micromedex2/librarian/deeplinkaccess?source=deepLink&institution=SZMC%5ESZMC%5ET43537

Note: To access the following medications, use the IBM Micromedex resource. Type the name of each medication in the keyword search bar. Be sure to read all sections on the left navigation bar related to each medication’s result page, as this information will be helpful for your review in preparation for your Assignments.

   

· alprazolam

· amitriptyline

· amoxapine

· amphetamine

· desipramine

· diazepam

· doxepin

· eszopiclone

· flunitrazepam

· flurazepam

· hydroxyzine

·  imipramine

· lemborexant

· lorazepam

· melatonin

· methylphenedate

· modafinil

· armodafinil

· carnitine

· clomipramine

· clonazepam

· nortriptyline

· pitolisant

· ramelteon

· sodium oxybate

· solriamfetol

· SSRI’s

· temazepam

· trazodone

· triazolam

· trimipramine

· wellbutrin

· zaleplon

· zolpidem

Required Media (click to expand/reduce)

https://mym.cdn.laureate-media.com/2dett4d/Walden/NURS/6630/DT/week_11/index.html

Required Media (click to expand/reduce

  

Assignment 1: Short Answer Assessment

As a psychiatric nurse practitioner, you will likely encounter patients who suffer from various mental health disorders. Not surprisingly, ensuring that your patients have the appropriate psychopharmacologic treatments will be essential for their overall health and well-being. The psychopharmacologic treatments you might recommend for patients may have potential impacts on other mental health conditions and, therefore, require additional consideration for positive patient outcomes. For this Assignment, you will review and apply your understanding of psychopharmacologic treatments for patients with multiple mental health disorders.

Photo Credit: Getty Images/Collection Mix: Sub

To Prepare

· Review the Learning Resources for this week.

· Reflect on the psychopharmacologic treatments that you have covered up to this point that may be available to treat patients with mental health disorders.

· Consider the potential effects these psychopharmacologic treatments may have on co-existing mental health conditions and/or their potential effects on your patient’s overall health.

To complete:

Address the following Short Answer prompts for your Assignment. Be sure to include references to the Learning Resources for this week.

1. In 3 or 4 sentences, explain the appropriate drug therapy for a patient who presents with MDD and a history of alcohol abuse. Which drugs are contraindicated, if any, and why? Be specific. What is the timeframe that the patient should see resolution of symptoms?

2. List 4 predictors of late onset generalized anxiety disorder.

3. List 4 potential neurobiology causes of psychotic major depression.

4. An episode of major depression is defined as a period of time lasting at least 2 weeks. List at least 5 symptoms required for the episode to occur. Be specific.

5. List 3 classes of drugs, with a corresponding example for each class, that precipitate insomnia. Be specific. 

Assignment 2: Assessing and Treating Patients With Sleep/Wake Disorders

Sleep disorders are conditions that result in changes in an individual’s pattern of sleep (Mayo Clinic, 2020). Not surprisingly, a sleep disorder can affect an individual’s overall health, safety, and quality of life. Psychiatric nurse practitioners can treat sleep disorders with psychopharmacologic treatments, however, many of these drugs can have negative effects on other aspects of a patient’s health and well-being. Additionally, while psychopharmacologic treatments may be able to address issues with sleep, they can also exert potential challenges with waking patterns. Thus, it is important for the psychiatric nurse practitioner to carefully evaluate the best psychopharmacologic treatments for patients that present with sleep/wake disorders.

Reference: Mayo Clinic. (2020). Sleep disorders. https://www.mayoclinic.org/diseases-conditions/sleep-disorders/symptoms-causes/syc-20354018

To prepare for this Assignment:

· Review this week’s Learning Resources, including the Medication Resources indicated for this week.

· Reflect on the psychopharmacologic treatments you might recommend for the assessment and treatment of patients with sleep/wake disorders.

The Assignment: 5 pages

Examine Case Study: Pharmacologic Approaches to the Treatment of Insomnia in a Younger Adult. You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patient’s pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

· Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.

Decision #1 (1 page)

· Which decision did you select?

· Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

· Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #2 (1 page)

· Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

· Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

· Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.

· What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).

· Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Conclusion (1 page)

· Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.

NOTE

FOR THIS ASSIGNMENT, YOU WILL WORK WITH :

DECISION 1: TRAZADONE 50-100 MG DAILY AT BEDTIME.

DECISION 2: DECREASE TRAZADONE TO 25 MG AT BEDTIME

DECISION 3 : CONTINUE TRAZADONE AND ENCOURAGE SLEEP HYGIENE.